Reports
Reports
Sale
The global aortic valve replacement market size was valued at USD 11.21 billion in 2023, driven by the increasing prevalence of valvular disorders across the globe. The market size is anticipated to grow at a CAGR of 12.1% during the forecast period of 2024-2032 to achieve a value of USD 31.23 billion by 2032.
In the human heart, there are four valves that control the blood flow in the heart, one of which is aortic valve. Aortic valves also control blood flow in the heart. The left ventricle and the main artery of the body, also known as aorta, are separated by the aortic valve. As the main function of an aortic valve is to control the blood flow in human body, a damaged or disease influenced aortic valve might probably affect the usual blood flow patterns and make it harder for the heart to perform its job of sending blood throughout the human body. In such conditions where aortic valve does not work properly or at all, the aortic valve replacement or aortic valve repairing are the procedures which are suggested and performed by healthcare professionals on the patient’s heart to cure or treat the condition.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Depending on the condition of the aortic valve, the healthcare professional may suggest getting it checked regularly but most of the times the condition requires frequent attention and treatment due to the severe issues in the aortic valve. These issues require instant attention such as surgical procedures that reduce the chances of the risks involved with the underlying condition, which includes high risks of getting a heart attack and stroke, among others. The major conditions that require instant treatment through aortic valve replacement or repairing include aortic valve regurgitation and aortic valve stenosis, among others.
Transcatheter aortic valve replacement (TAVR) is another key procedure which is performed to treat a condition called aortic stenosis. In this procedure, the damaged aortic valve is being replaced with an aortic valve which is made from animal tissues.
The dramatically increasing demand for TAVR is a major trend aiding the growth of the market. Consequently, the governments are putting in efforts and higher investments in the healthcare sector, significantly aiding the aortic valve replacement market development. The increasing research to develop cost-effective structural initiatives to address gaps in access to this crucial surgery is another key factor propelling the growth of the market. The increasing rates of valvular disorders, especially amongst the ageing population, are also providing a significant impetus to the market growth. The increasing technological advancement in the surgical procedure for aortic valve replacement is also influencing the market expansion.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product Type
Market Breakup by Procedure
Market Breakup by End User
Market Breakup by Region
The aortic valve replacement is a surgical process which is performed to treat diseased or malfunctioned aortic valve whose main function is to keep the blood flow under control. The global market for aortic valve replacement is growing significantly from the past few years and is expected to keep on growing in coming years as well due to the rising cases of heart diseases globally and lifestyle changes and unhealthy eating habits explicitly. The increasing prevalence of aortic stenosis is a major factor aiding the market growth.
The increasing numbers of heart surgeries worldwide are also contributing to the global aortic valve replacement market expansion. The increasing ageing population is also aiding the market growth as the ageing population is most prone to suffer from several kind of heart diseases. The increasing demand for transcatheter aortic valve replacement (TAVR) is equally intensifying the aortic valve replacement market growth.
North America is leading the global market for aortic valve replacements owing to the developed healthcare sectors, equipped with all the latest technologies and surgeons. The availability of high-end equipment and devices to perform the procedure, along with robust healthcare infrastructure is a major factor supporting the growth of the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and
|
Breakup by Product |
|
Breakup by Procedure |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Aortic Valve Replacement Market Overview
3.1 Global Aortic Valve Replacement Market Historical Value (2017-2023)
3.2 Global Aortic Valve Replacement Market Forecast Value (2024-2032)
4 Global Aortic Valve Replacement Market Landscape
4.1 Global Aortic Valve Replacement Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Aortic Valve Replacement Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Procedure
4.2.3 Analysis by End User
4.2.4 Analysis by Region
5 Global Aortic Valve Replacement Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Aortic Valve Replacement Market Segmentation
6.1 Global Aortic Valve Replacement Market by Product Type
6.1.1 Market Overview
6.1.2 Valve Type
6.1.2.1 Tissue/Biological
6.1.2.2 Mechanical
6.1.3 Suture Type
6.1.3.1 Sutured
6.1.3.2 Sutureless
6.1.4 Sheet Hydrogel
6.2 Global Aortic Valve Replacement Market by Procedure
6.2.1 Market Overview
6.2.2 Minimally Invasive
6.2.3 Transfemoral Aortic Valve Replacement (TF-AVR)
6.2.4 Transcatheter Aortic Valve Replacement (TAVR)
6.2.5 Open Surgery
6.2.6 Others
6.3 Global Aortic Valve Replacement Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Ambulatory Surgical Centres
6.3.4 Others
6.4 Global Aortic Valve Replacement Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Aortic Valve Replacement Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Aortic Valve Replacement Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Aortic Valve Replacement Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Aortic Valve Replacement Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Aortic Valve Replacement Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic Plc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 LivaNova PLC
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 CryoLife, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Edwards Lifesciences Corporation
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Micro Interventional Devices
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Meril Life Sciences Pvt. Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 JenaValve Technology, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Auto Tissue Berlin GmbH
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Abbott
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 TTK HealthCare
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Aortic Valve Replacement Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 11.21 billion in 2023, driven by the rising prevalence of heart ailments.
The market size is anticipated to grow at a CAGR of 12.1% during the forecast period of 2024-2032 to reach a value of USD 31.23 billion by 2032.
The major factors aiding the growth of the market include the rapidly rising geriatric population, rising prevalence of heart disorders, and the rapidly rising demand for transcatheter aortic valve replacement.
The decreasing cost of transcatheter aortic valve replacement, which is directly increasing the number of aortic valve replacements globally, is a major trend supporting the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America has been leading the global market.
The different products in the market are valve type, suture type, and sheet hydrogel. Valve type is further divided into tissue/biological and mechanical. Suture type is further divided into sutured and sutureless.
Procedures followed in aortic valve replacement procedure include minimally invasive, transfemoral aortic valve replacement (TF-AVR), transcatheter aortic valve replacement (TAVR), and open surgery, among others.
The end users in the market include hospitals and ambulatory surgical centres, among others.
Key players involved in the market are Medtronic Plc., LivaNova PLC, CryoLife, Inc., Edwards Lifesciences Corporation, Micro Interventional Devices, Meril Life Sciences Pvt. Ltd., JenaValve Technology, Inc., Auto Tissue Berlin GmbH, Abbott, and TTK HealthCare.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.